The association of the administration of EGFR -TKI as 1stt-line setting and subsequent BM occurrence among 105 stage IIIB-IV patients without BM at the diagnosis of mutated-EGFR NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.